Schedule 13G ownership disclosure

Petros Pharmaceuticals, Inc.

Security class unavailable · CUSIP: 71678J100

Event date: 2020-12-01

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
579,003
Percent of class
5.7000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001213900-21-003226
Form type
SC 13G
Filer
INTRACOASTAL CAPITAL, LLC
CIK
CIK 1646799
Filed
Jan 20, 2021
Reporting period
Dec 01, 2020
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub